Search Orphan Drug Designations and Approvals
-
Generic Name: | (7S)-3-Amino-14-ethyl-11-fluoro-7-methyl-4-oxo-4,5,6,7,13,14-hexahydro-1,15-ethenopyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecine-12-carbonitrile |
---|---|
Date Designated: | 05/25/2021 |
Orphan Designation: | Treatment of gastric cancer, including gastroesophageal junction adenocarcinoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Bristol Myers Squibb 3401 Princeton Pike Lawrenceville, New Jersey 08648 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-